Overview

Baclofen Treatment of Ataxia Telangiectasia

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out if Baclofen, a medicine that is often used for the treatment of abnormal stiffness, might also be useful to treat some of the neurologic problems caused by ataxia telangiectasia (A-T). The investigators also want to find out if there are better ways to measure the problems of ataxia and abnormal eye movement for future studies of medication in ataxia telangiectasia.
Phase:
Early Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Baclofen